Variables | Total population | Stroke | No stroke | p Value |
---|---|---|---|---|
Age (years) | 66.9±12.8 | 71.3±10.2 | 66.7±12.9 | <0.010 |
Female sex | 27.9% | 33.2% | 27.6% | 0.101 |
GRACE 6 months | 112.9±33.4 | 123.8±30.5 | 112.5±33.5 | <0.010 |
CHA2DS2VASc | 2.7±1.9 | 3.4±1.8 | 2.6±1.8 | <0.010 |
MDRD-4 (mL/min/1.73 m2) | 74.9±39.3 | 68.8±23.7 | 75.1±39.8 | 0.032 |
TNI peak (ng/mL) | 28.9±123.8 | 20.8±40.6 | 29.3±126.2 | 0.366 |
Hypertension | 57.1% | 66.3% | 56.7% | 0.010 |
Diabetes | 26.5% | 35.9% | 26.0% | 0.003 |
Hypercholesterolemia | 45.2% | 46.2% | 45.1% | 0.779 |
Previous CAD | 23.1% | 29.9% | 22.8% | 0.026 |
Previous stroke | 6.8% | 14.1% | 6.5% | <0.001 |
Previos atrial fibrillation | 10.5% | 16.8% | 10.3% | 0.004 |
Hospitalisation | ||||
EF <40% | 12.8% | 14.1% | 12.7% | 0.576 |
STEMI | 31.5% | 27.7% | 31.7% | 0.256 |
Multivessel | 37.4% | 32.1% | 37.7% | 0.124 |
PCI | 64.2% | 56.5% | 64.5% | 0.027 |
At discharge | ||||
Dual antiplatelet therapy | 71.1% | 65.2% | 71.3% | 0.074 |
Warfarin | 7.4% | 10.9% | 7.2% | 0.062 |
ACEI/A2 blocker | 60.3% | 60.3% | 60.3% | 0.999 |
Statins | 83.3% | 79.3% | 83.5% | 0.141 |
β-Blocker | 67.7% | 66.3% | 67.8% | 0.669 |
Values are n (%) or median (IQR).
MDRD-4, glomerular filtration rate calculated by MDRD Formula for glomerular filtration rate.
A2 blocker, angiotensin II receptor blocker; ACEI, ACE inhibitor; CAD, coronary artery disease; EF, ejection fraction; GRACE, Global Registry of Acute Coronary Events; MDRD, modification of diet in renal disease; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; TNI, troponin.